NCT06311123View on ClinicalTrials.gov

Understanding Ozanimod's MOA Via Mass Cytometry in Ulcerative Colitis

RecruitingOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

October 6, 2023

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions
Ulcerative ColitisUlcerative Colitis Chronic Moderate
Trial Locations (1)

92093-006

RECRUITING

University of California San Diego, San Diego

All Listed Sponsors
lead

University of California, San Diego

OTHER

NCT06311123 - Understanding Ozanimod's MOA Via Mass Cytometry in Ulcerative Colitis | Biotech Hunter | Biotech Hunter